FIELD: medicine.
SUBSTANCE: method involves introducing single injection of 0.3-0.5 ml of 8% combined hydrogel solution of chytosan ascorbate of 94-98% deacetylization, molecular mass of 100-700 kDa containing 200 mg of hyaluronic acid in 1 l of solution, 2 g of chondroitin-sulfuric acid, 110-440 mg of kettle serum growth factor and 50 mg of heparin.
EFFECT: enhanced effectiveness in strengthening thin sclera in short time.
5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF CENTRAL ATHEROSCLEROTIC CHORIORETINOPATHY | 2005 |
|
RU2281775C1 |
| METHOD FOR PROPHYLAXIS OF MYOPIA PROGRESSING | 2005 |
|
RU2275917C1 |
| METHOD FOR TREATMENT OF DIABETIC RETINOPATHY WITH PREPARATION "BOL-KHIT" | 2006 |
|
RU2301675C1 |
| METHOD FOR TREATING OPTIC NERVE ATROPHY CASES | 2006 |
|
RU2309749C1 |
| METHOD FOR GLAUCOMA TREATMENT WITH NON-STABILIZED VISUAL FUNCTIONS | 2005 |
|
RU2299732C1 |
| METHOD FOR TREATING DEGENERATIVE MYOPIA | 2006 |
|
RU2308952C1 |
| METHOD OF CONSERVATIVE TREATMENT OF ADAPTED PENETRATING WOUNDS OF THE CORNEA | 2016 |
|
RU2644701C1 |
| METHOD FOR NONOPERATIVELY STRENGTHENING SCLERA IN CASE OF PROGRESSING MYOPIA | 1991 |
|
RU2020907C1 |
| METHOD OF TREATING PROGRESSIVE MYOPIA WITH APPLICATION OF SCLERA COLLAGEN CROSS-LINKING | 2014 |
|
RU2558997C1 |
| WOUND COAT BASED ON COLLAGEN-CHITOSAN COMPLEX | 2003 |
|
RU2254145C1 |
